Re RNS16 Feb 2026 11:42
I like this bit,—The Company continues to make progress across all its key growth initiatives, continuing to diversify its services, enhancing its internal quality management system and processes, whilst making positive steps forward with its Personalised Dosing Software.— This is ripe for a buyout imho,